The U.S. Food and Drug Administration (FDA) today approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability, and include aggression, deliberate self-injury, and temper tantrums.
-
1
- 2
View Full Article
Reprinted with the permission of the U.S. Food and Drug Administration.
Ask a Question
Have questions about this article or topic? Ask150 Characters allowed
Related Questions
See More QuestionsToday on Education.com
HOME COOKING
10 Ways to Spice Up Your Barbecue
BOOK PICKS
Summer Reading
CELEBRATION
Happy Graduation
Popular Articles
Wondering what others found interesting? Check out our most popular articles.
- 20 Great Graduation Quotes
- Examining Possible Causes of ADHD
- Can Inventiveness Be Taught?
- What Do Test Scores Really Say About a School?
- Great Gifts for Middle School Grads
- Unraveling the Mystery of the Allergy Epidemic
- 9 Ways to Encourage Early Literacy
- Ten Great High School Graduation Gifts
- Is High-Stakes Testing Cheating Your Kid?
- Picky Eaters: Tips for Tackling and Myths Debunked
Add your own comment